These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3305191)

  • 1. The BFM relapse studies in childhood ALL: concepts of two multicenter trials and results after 2 1/2 years.
    Henze G; Buchmann S; Fengler R; Hartmann R
    Haematol Blood Transfus; 1987; 30():147-55. PubMed ID: 3305191
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis.
    Riehm H; Feickert HJ; Schrappe M; Henze G; Schellong G
    Haematol Blood Transfus; 1987; 30():139-46. PubMed ID: 3476353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81].
    Schrappe M; Beck J; Brandeis WE; Feickert HJ; Gadner H; Graf N; Havers W; Henze G; Jobke A; Kornhuber B
    Klin Padiatr; 1987; 199(3):133-50. PubMed ID: 3306128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
    Niemeyer CM; Ritz J; Donahue K; Sallan SE
    Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic marrow transplantation for treatment of leukemia: results of the Munich Cooperative Group.
    Kolb HJ; Bender-Götze C; Haas RJ; Thierfelder S; Wilmanns W
    Haematol Blood Transfus; 1987; 30():204-12. PubMed ID: 3305196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of acute lymphoblastic leukemia in children].
    Masera G; Jankovic M; Uderzo C; Adamoli L; Locasciulli A; Rossi MR; Zurlo MG; Cantu' Rajnoldi A; Cattoretti G
    Recenti Prog Med; 1984 Oct; 75(10):922-35. PubMed ID: 6393242
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia: current status of therapy in children.
    Lampert F; Henze G; Langermann HJ; Schellong G; Gadner H; Riehm HJ
    Recent Results Cancer Res; 1984; 93():159-81. PubMed ID: 6382478
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia of childhood.
    Cohen DL; Duval-Arnould B; Olson TA
    Am Fam Physician; 1984 Oct; 30(4):236-45. PubMed ID: 6388294
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features.
    Gaynon PS; Steinherz PG; Reaman GH; Bleyer WA; Sather H; Hammond GD
    Haematol Blood Transfus; 1987; 30():167-72. PubMed ID: 3305193
    [No Abstract]   [Full Text] [Related]  

  • 10. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
    Barrett AJ; Joshi R; Tew C
    Lancet; 1985 May; 1(8439):1188-91. PubMed ID: 2860389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of ALL/AUL therapy in adults.
    Hoelzer D
    Recent Results Cancer Res; 1984; 93():182-203. PubMed ID: 6382479
    [No Abstract]   [Full Text] [Related]  

  • 12. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
    Henze G; Fengler R; Hartmann R; Niethammer D; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():619-26. PubMed ID: 2182452
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic meaning of chromosome aberrations in acute lymphocytic leukemia and acute nonlymphocytic leukemia patients of the BFM Study Group.
    Harbott J; Budde M; Creutzig U; Engel R; Fengler R; Rudolph B; Lampert F
    Haematol Blood Transfus; 1987; 30():497-503. PubMed ID: 3476381
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of childhood acute lymphoblastic leukaemia.
    Lancet; 1988 Mar; 1(8587):683-5. PubMed ID: 2895215
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
    Ritter J; Creutzig U; Schellong G
    Haematol Blood Transfus; 1990; 33():185-92. PubMed ID: 2182410
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experiences with a modified BFM protocol in childhood acute lymphoblastic leukemia.
    Zintl F; Malke H; Plenert W
    Haematol Blood Transfus; 1985; 29():84-9. PubMed ID: 3896979
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic.
    Zintl F; Plenert W; Malke H
    Haematol Blood Transfus; 1987; 30():471-9. PubMed ID: 3305215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group].
    Müller-Weihrich S; Henze G; Langermann HJ; Odenwald E; Riehm H
    Onkologie; 1984 Aug; 7(4):205-8. PubMed ID: 6384862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after therapy cessation in childhood acute lymphoblastic leukemia.
    Rokicka-Milewska R; Derulska D; Armata J; Balwierz W; Bogusławska-Jaworska J; Cyklis R; Duczmal B; Michalewska D; Newecka T; Ochocka M
    Haematol Blood Transfus; 1987; 31():37-8. PubMed ID: 3327777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Initial results of a study of the treatment of children with ALL recurrences].
    Henze G; Fengler R; Buchmann S
    Onkologie; 1986 Apr; 9(2):92-5. PubMed ID: 3520427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.